ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
<p class="mb-4"> Body Protection Compound-157 (BPC-157) has become a focal point in regenerative medicine due to its profound ability to accelerate the healing of soft tissues, particularly tendons, ligaments, and the gastrointestinal tract. This 15-amino-acid peptide, derived from a protein in gastric juice, exhibits remarkable stability and efficacy across various administration routes. </p> <p> A seminal study by Huang et al. (2015) utilized a localized drug delivery system to explore the peptide's efficacy. The results demonstrated that BPC-157 significantly accelerates wound closure rates in animal models. The study highlighted a key mechanism: the upregulation of Vascular Endothelial Growth Factor (VEGF), which stimulates the formation of new capillaries (angiogenesis) to "re-vascularize" damaged tissues. </p>
Body Protection Compound-157 (BPC-157) has become a focal point in regenerative medicine due to its profound ability to accelerate the healing of soft tissues, particularly tendons, ligaments, and the gastrointestinal tract.
A seminal study by Huang et al. (2015) utilized a localized drug delivery system to explore the peptide's efficacy. The results demonstrated that BPC-157 significantly accelerates wound closure rates in animal models. The study highlighted a key mechanism: the upregulation of Vascular Endothelial Growth Factor (VEGF).
VEGF is the signal protein that stimulates the formation of blood vessels. By increasing VEGF expression, BPC-157 effectively "re-vascularizes" damaged tissue. This is particularly critical for tendons and ligaments, which notoriously suffer from poor blood supply, leading to slow recovery times.
Further research by Vukusić et al. (2020) focused on the stability of the pentadecapeptide. Unlike many peptides that degrade rapidly, BPC-157 remains stable in human gastric juice for over 24 hours. This stability allows for diverse administration routes (oral, topical, or systemic) while maintaining biological activity.
"BPC 157 accelerates the healing of various wounds, including alkali burns and diabetic ulcers, by modulating the NO-cGMP pathway, which controls blood flow and tissue repair signaling." — Vukusić et al., Frontiers in Pharmacology (2020)
Current literature suggests BPC-157 acts as a comprehensive "healing coordinator," promoting angiogenesis and protecting cell survival under stress.
